Anticolorectal Cancer Properties of Some Flavonoids and Terpenoids from African Propolis via Molecular Docking
Published: 2022-12-30
Page: 209-221
Issue: 2022 - Volume 5 [Issue 3]
Sylvester Nnaemeka Ugariogu
*
Chemistry Department Federal University of Technology, Owerri, Nigeria.
Ijeoma Akunna Duru
Chemistry Department Federal University of Technology, Owerri, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Propolis, a resinous material produced by bees from plant exudates, has long been reported to be used in traditional herbal medicine and is widely consumed as a health aid and immune system booster. The colorectal cancer which is a world health emergency has renewed interest in propolis products worldwide. Fortunately, various aspects of the Poly adenosine diphosphate ribose polymerases (PARPs) mechanism are potential targets for propolis compounds. The treatment of Colerectal cancer (CRC) has been focused on the tumor site and stage of the disease using chemotherapy or radiotherapy, surgery, hormonal therapy, immunotherapy etc. Although apoptosis is being used in preventing damaged cells from developing out but due to secondary mutations in apoptosis-regulating gene, it can distort this order. This work aimed at evaluating the anticancer potential of some flavonoids and terpenoids from African propolis which can inhibit the protein of PARPs therefore preventing the growth of the cancer cell. From the result β- amyrin and naringin showed the best binding affinity and fit at -11.9 kcal/mol and -11.7 kcal/mol respectively which were better than standard drugs Irinotecan -11.2 kcal/mol and Doxorubicin -9.1 kcal/mol with the ligand at -11.2 kcal/mol. Other compounds also showed very high binding affinity of more than -9.0 kcal/mol suggesting the propolis compounds as potential anticancer compounds.
Keywords: Molecular docking, anticolorectal cancer, propolis, poly (ADP-ribose) polymerases (PARPs), flavonoids
How to Cite
Downloads
References
Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP. Risk factors and preventions of breast cancer. International Journal of Biological Sciences. 2017;13(11):1387–1397.
Available:https://doi.org/10.7150/ijbs.21635
Cui W, Aouidate A, Wang S, Yu Q, Li Y, Yuan S. Discovering anti-cancer drugs via computational methods. Frontiers in Pharmacology. 2020;11:733.
Available:https://doi. org/10.3389/fphar.2020.00733.
Yan B, Yang WJ, Han XY, Han LH. Crystal structures and antitumor activity evaluation against gastric carcinoma of two novel coordination polymers. Main Group Chem. 2019;18:239–246.
DOI: 10.3233/MGC-180748
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-a Cancer J. Clin. 2018;68:394–424.
DOI: 10.3322/caac.21492
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J. Clin. 2021;71:7–33,
Available:https://doi.org/10.3322/caac.21654.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 2021:1–41.
Available:https://doi.org/10.3322/caac.21660
Hagan TL, Donovan HS. Self-advocacy and cancer: A concept analysis. J. Adv. Nurs. 2013;69(10):2348–2359.
Available:https://doi.org/10.1111/jan.12084
Zhang X, Li K, Feng J, Liu G, Feng Y. Blocking the IGF2BP1-promoted glucose metabolism of colon cancer cells via direct de-stabilizing mRNA of the LDHA enhances anticancer effects. Mol. Ther. Nucleic Acids; 2021.
Available:https://doi.org/10.1016/j.omtn.2020.12.020
Parmar F, Patel C, Highland H, Pandya H, George LB. Antiproliferative efficacy of kaempferol on cultured daudi cells: An in silico and in vitro study. Adv. Biol. 2016:1–10.
Available:https://doi.org/10.1155/2016/9521756.
Sharma V, Janmeda P. Extraction, isolation and identification of flavonoid from Euphorbia neriifolia leaves. Arab. J. Chem. 2017;10(4):509–514.
Available:https://doi.org/10.1016/j. arabjc.2014.08.019
Liu H, Yang J, Li L, Shi W, Yuan X, Wu L. The natural occurring compounds targeting endoplasmic reticulum stress. Evid. Based Complement. Alternat. Med; 2016.
Available:https://doi.org/10.1155/2016/7831282 7831282
Patridge E, Gareiss P, Kinch MS, Hoyer D. An analysis of FDA-approved drugs: Natural products and their derivatives. Drug Discov Today. 2016;21(2):204–207.
Available:https://doi.org/ 10.1016/j.drudis.2015.01.009.
Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 2012;75(3):311–335.
Available:https://doi.org/10.1021/np200906s
Mishra BB, Tiwari VK. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem. 2011;46(10):4769–4807.
Available:https://doi.org/10.1016/j.ejmech.2011.07.057.
Ugariogu SN, Duru IA, Onwumere FC, Igoli JO. Physicochemical assessment and drug potential of some phenylpropanoid and flavonoid compounds of ethyl acetate eluate from umudike propolis. Trop J Nat Prod Res. 2020;4(12):1208-1214.
DOI: 10.26538/tjnpr/v4i12.30
Ugariogu SN, et al. Preliminary pharmaceutical active ingredient and micronutrient evaluation of the leaf of Corchorus olitorius (Ahiahara). Nat Ayurvedic Med. 2020,;4(2):000233.
Blicharska N, Seidel V. Chemical diversity and biological activity of African propolis. ©Springer Nature Switzerland AG. Kinghorn AD, Falk H, Gibbons S, Kobayashi J, Asakawa Y, Liu JK (eds.) Progress in the Chemistry of Organic Natural Products. 2019;109.
Available:https://doi.org/10.1007/978-3-030-12858-6_3
Hemalatha T, Umamaheswari T, Krithiga G, Sankaranarayanan P, Puvanakrishnan R. Enzymes in clinical medicine: An overview. Indian J Exp Biol. 2013;51(10): 777-788.
PMID 24266101
Lehtio L, et al. Structural basis for inhibitor specificity in human poly (ADP-ribose) polymerase-3 J Med Chem. 2009;52(9):3108-3111.
Southan GJ, Szabo C. Poly(ADP-Ribose) polymerase inhibitors. Current Medicinal Chemistry. 2003;10(4):321-340
Ikwu FA, Isyaku Y, Obadawo, BS, Lawal HA and Ajibowu SA. In silico design and molecular docking study of CDK-2 inhibitors with potent cytotoxic activity against HCT 116 colorectal cancer cell line. Journal of Genetic Engineering and Biotechnology. 2020;18(51):1-12.
Irinotecan.
Available:https://go.drugbank.com/drugs/DB00762 23/02/2023
Doxorubicin.
Available:https://www.cancerresearchuk.org/about-cancer/treatment/drugs/doxorubicin
Access on 23/02/2023